c-kit ligand and flt3 ligand: Stem/progenitor cell factors with overlapping yet distinct activities

Blood

Volumn 91, Issue 4, 1998, Pages 1101-1134

  Lyman, Stewart D ^a   Jacobsen, Sten Eirik W ^b  

^a AMGEN INC   (United States)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

TYROSINE KINASE RECEPTOR;

AMINO ACID SEQUENCE; GENE LOCUS; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HUMAN; LIGAND BINDING; PRIORITY JOURNAL; REVIEW;

EID: 0032519768     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v91.4.1101     Document Type: Review

References (434)

1. Spangrude GJ, Smith L, Uchida N, Ikuta K, Heimfeld S, Friedman J, Weissman IL: Mouse hematopoietic stem cells. Blood 78:1395, 1991
2. Ogawa M: Differentiation and proliferation of hematopoietic stem cells. Blood 81:2844, 1993
3. Moore MA: Review: Stratton Lecture 1990. Clinical implications of positive and negative hematopoietic stem cell regulators. Blood 78:1, 1991
4. Metcalf D: Hematopoietic regulators: Redundancy or subtlety? Blood 82:3515, 1993
5. Broudy VC: Stem cell factor and hematopoiesis. Blood 90:1345, 1997
6. Galli SJ, Zsebo KM, Geissler EN: The kit ligand, stem cell factor. Adv Immunol 55:1, 1994
7. Namikawa R, Muench MO, Roncarolo MG: Regulatory roles of the ligand for flk2/flt3 tyrosine kinase receptor on human hematopoiesis. Stem Cells 14:388, 1996
8. McNiece IK, Briddell RA: Stem cell factor. J Leukoc Biol 58:14, 1995
9. Silvers WK: Dominant Spotting, Patch, and Rump-White, in Silvers WK (eds): The Coat Colors of Mice: A Model for Mammalian Gene Action and Interaction. New York, NY, Springer-Verlag, 1979, p 206
10. Russell ES: Hereditary anemias of the mouse: A review for geneticists. Adv Genet 20:357, 1979
11. Chabot B, Stephenson DA, Chapman VM, Besmer P, Bernstein A: The proto-oncogene c-kit encoding a transmembrane tyrosine kinase receptor maps to the mouse W locus. Nature 335:88, 1988
12. Geissler EN, Ryan MA, Houseman DE: The dominant-white spotting (W) locus of the mouse encodes the c-kit proto-oncogene. Cell 55:185, 1988
13. Coussens L, Van Beveren C, Smith D, Chen E, Mitchell RL, Isacke CM, Verma IM, Ullrich A: Structural alteration of viral homologue of receptor proto-oncogene fms at carboxyl terminus. Nature 320:277, 1986
14. Woolford J, McAuliffe A, Rohrschneider LR: Activation of the feline c-fms proto-oncogene: Multiple alterations are required to generate a fully transformed phenotype. Cell 55:965, 1988
15. Rothwell VM, Rohrschneider LR: Murine c-fms cDNA: Cloning, sequence analysis and retroviral expression. Oncogene Res 1:311, 1987
16. Rosnet O, Schiff C, Pébusque M-J, Marchetto S, Tonnelle C, Toiron Y, Birg F, Birnbaum D: Human FLT3/FLK2 gene: cDNA cloning and expression in hematopoietic cells. Blood 82:1110, 1993
17. + human bone marrow cells and is involved in the proliferation of early progenitor/stem cells. Proc Natl Acad Sci USA 91:459, 1994
18. Rosnet O, Marchetto S, deLapeyriere O, Birnbaum D: Murine Flt3, a gene encoding a novel tyrosine kinase receptor of the PDGFR/ CSF1R family. Oncogene 6:1641, 1991
19. Matthews W, Jordan CT, Wiegand GW, Pardoll D, Lemischka IR: A receptor tyrosine kinase specific to hematopoietic stem and progenitor cell-enriched populations. Cell 65:1143, 1991
20. Yarden Y, Escobedo JA, Kuang WJ, Yang-Feng TL, Daniel TO, Tremble PM, Chen EY, Ando ME, Harkins RN, Francke U, Fried VA, Ullrich A, Williams LT: Structure of the receptor for platelet-derived growth factor helps define a family of closely related growth factor receptors. Nature 323:226, 1986
21. Gronwald RG, Grant FJ, Haldeman BA, Hart CE, O'Hara PJ, Hagen FS, Ross R, Bowen-Pope DF, Murray MJ: Cloning and expression of a cDNA coding for the human platelet-derived growth factor receptor: Evidence for more than one receptor class. Proc Natl Acad Sci USA 85:3435, 1988
22. Claesson-Welsh L, Eriksson A, Moren A, Severinsson L, Ek B, Ostman A, Betsholtz C, Heldin CH: cDNA cloning and expression of a human platelet-derived growth factor (PDGF) receptor specific for B-chain-containing PDGF molecules. Mol Cell Biol 8:3476, 1988
23. Matsui T, Heidaran M, Miki T, Popescu N, La Rochelle W, Kraus M, Pierce J, Aaronson S: Isolation of a novel receptor cDNA establishes the existence of two PDGF receptor genes. Science 243:800, 1989
24. Bernstein A, Forrester L, Reith AD, Dubreuil P, Rottapel R: The murine W/c-kit and Steel loci and the control of hematopoiesis. Semin Hematol 28:138, 1991
25. Herbst R, Shearman MS, Obermeier A, Schlessinger J, Ullrich A: Differential effects of W mutations on p145c-kit tyrosine kinase activity and substrate interaction. J Biol Chem 267:13210, 1992
26. 41 and W. EMBO J 9:1805, 1990
27. Reith AD, Rottapel R, Giddens E, Brady C, Forrester L, Bernstein A: W mutant mice with mild or severe developmental defects contain distinct point mutations in the kinase domain of the c-kit receptor. Genes Dev 4:390, 1990
28. 42 spotting phenotype results from a missense mutation in the c-kit receptor kinase. Science 247:209, 1990
29. Sarvella PA, Russell LB: Steel, a new dominant gene in the house mouse. J Hered 47:123, 1956
30. Silvers WK: Steel, Flexed-Tailed, Splotch, and Varitint-Waddler, in Silvers WK (eds): The Coat Colors of Mice: A Model for Mammalian Gene Action and Interaction. New York, NY, Springer-Verlag, 1979, p 242
31. Stubbs L, Poustka A, Rohme D, Russell LB, Lehrach H: Approaching the mouse Steel locus from closely linked molecular markers, in Clarke A, Compans RW, Cooper M, Eisen H, Goebel W, Koprowsi H, Melchers F, Oldstone M, Vogt PK, Wagner H, Wilson I (eds): Current Topics in Microbiology and Immunology. Berlin, Germany, Springer-Verlag, 1988, p 47
32. Huang E, Nocka K, Beier DR, Chu T-Y, Buck J, Lahm HW, Wellner D, Leder P, Besmer P: The hematopoietic growth factor KL is encoded by the Sl locus and is the ligand of the c-kit receptor, the gene product of the W locus. Cell 63:225, 1990
33. Martin FH, Suggs SV, Langley KE, Lu HS, Ting J, Okino KH, Morris CF, McNiece IK, Jacobsen FW, Mendiaz EA, Birkett NC, Smith KA, Johnson MJ, Parker VP, Flores JC, Patel AC, Fisher EF, Erjavec HO, Herrera CJ, Wypych J, Sachdev RK, Pope JA, Leslie I, Wen D, Lin C, Cupples RL, Zsebo KM: Primary structure and functional expression of rat and human stem cell factor DNAs. Cell 63:203, 1990
34. Williams DE, Eisenman J, Baird A, Rauch C, Van Ness K, March CJ, Park LS, Martin U, Mochizuki DY, Boswell HS, Burgess GS, Cosman D, Lyman SD: Identification of a ligand for the c-kit proto-oncogene. Cell 63:167, 1990
35. Copeland NG, Gilbert DJ, Cho BC, Donovan PJ, Jenkins NA, Cosman D, Anderson D, Lyman SD, Williams DE: Mast cell growth factor maps near the Steel locus on mouse chromosome 10 and is deleted in a number of Steel alleles. Cell 63:175, 1990
36. Zsebo KM, Williams DA, Geissler EN, Broudy VC, Martin FH, Atkins HL, Hsu RY, Birkett NC, Okino KH, Murdock DC, Jacobsen FW, Langley KE, Smith KA, Takeishi T, Cattanach BM, Galli SJ, Suggs SV: Stem cell factor is encoded at the Sl locus of the mouse and is the ligand for the c-kit tyrosine kinase receptor. Cell 63:213, 1990
37. Zhou J-H, Ohtaki M, Sakurai M: Sequence of a cDNA encoding chicken stem cell factor. Gene 127:269, 1993
38. Petitte JN, Kulik MJ: Cloning and characterization of cDNAs encoding two forms of avian stem cell factor. Biochim Biophys Acta 1307:149, 1996
39. Shull RM, Suggs SV, Langley KE, Okino KH, Jacobsen FW, Martin FH: Canine stem cell factor (c-kit ligand) supports the survival of hematopoietic progenitors in long-term canine marrow culture. Exp Hematol 20:1118, 1992
40. Anderson DM, Williams DE, Tushinski R, Gimpel S, Eisenman J, Cannizzaro LA, Aronson M, Croce CM, Huebner K, Cosman D, Lyman SD: Alternate splicing of mRNAs encoding human mast cell growth factor and localization of the gene to chromosome 12q22-q24. Cell Growth Differ 2:373, 1991
41. Rosnet O, Mattel MG, Marcherto S, Birnbaum D: Isolation and chromosomal localization of a novel FMS-like tyrosine kinase gene. Genomics 9:380, 1991
42. Van Zant G, Eldridge PW, Behringer RR, Dewey MJ: Genetic control of hematopoietic kinetics revealed by analyses of allophenic mice and stem cell suicide. Cell 35:639, 1983
43. Iwama A, Okano K, Sudo T, Matsuda Y, Suda T: Molecular cloning of a novel receptor tyrosine kinase gene, STK, derived from enriched hematopoietic stem cells. Blood 83:3160, 1994
44. Lyman SD, James L, Zappone J, Sleath PR, Beckmann MP, Bird T: Characterization of the protein encoded by the flt3 (flk2) receptor-like tyrosine kinase gene. Oncogene 8:815, 1993
45. Zeigler FC, Bennett BD, Jordan CT, Spencer SD, Baumhueter S, Carroll KJ, Hooley J, Bauer K, Matthews W: Cellular and molecular characterization of the role of the FLK-2/FLT-3 receptor tyrosine kinase in hematopoietic stem cells. Blood 84:2422, 1994
46. Rossner MT, McArthur GA, Allen JD, Metcalf D: Fms-like tyrosine kinase 3 catalytic domain can transduce a proliferative signal in FDC-P1 cells that is qualitatively similar to the signal delivered by c-Fms. Cell Growth Differ 5:549, 1994
47. Dosil M, Wang S, Lemischka IR: Mitogenic signalling and substrate specificity of the Flk2/Flt3 receptor tyrosine kinase in fibroblasts and interleukin 3-dependent hematopoietic cells. Mol Cell Biol 13:6572, 1993
48. Lyman SD, James L, Vanden Bos T, de Vries P, Brasel K, Gliniak B, Hollingsworth LT, Picha KS, McKenna HJ, Splett RR, Çletcher FF, Maraskovsky E, Farrah T, Foxworthe D, Williams DE, Beckmann MP: Molecular cloning of a ligand for the flt3/flk-2 tyrosine kinase receptor: A proliferative factor for primitive hematopoietic cells. Cell 75:1157, 1993
49. Hannum C, Culpepper J, Campbell D, McClanahan T, Zurawski S, Bazan JF, Kastelein R, Hudak S, Wagner J, Mattson J, Luh J, Duda G, Martina N, Peterson D, Menon S, Shanafelt A, Muench M, Keiner G, Namikawa R, Rennick D, Roncarolo M-G, Zlotnick A, Rosnet O, Dubreuil P, Birnbaum D, Lee F: Ligand for FLT3/FLK2 receptor tyrosine kinase regulates growth of haematopoietic stem cells and is encoded by variant RNAs. Nature 368:643, 1994
50. Lyman SD, James L, Johnson L, Brasel K, de Vries P, Escobar SS, Downey H, Splett RR, Beckmann MP, McKenna HJ: Cloning of the human homologue of the murine flt3 ligand: a growth factor for early hematopoietic progenitor cells. Blood 83:2795, 1994
51. Lyman SD, Brasel K, Rousseau AM, Williams DE: The flt3 ligand: A hematopoietic stem cell factor whose activities are distinct from steel factor. Stem Cells 12:99, 1994
52. Matous JV, Langley K, Kaushansky K: Structure-function relationships of stem cell factor: An analysis based on a series of human-murine stem cell factor chimera and the mapping of a neutralizing monoclonal antibody. Blood 88:437, 1996
53. Qiu F, Ray P, Brown K, Barker PE, Jhanwar S, Ruddle FH, Besmer P: Primary structure of c-kit: Relationship with the CSF-1/ PDGF receptor kinase family-oncogenic activation of v-kit involves deletion of extracellular domain and C terminus. EMBO J 7:1003, 1988
54. Yarden Y, Kuang W-J, Yang-Feng T, Coussens L, Munemitsu S, Dull TJ, Chen E, Schlessinger J, Francke U, Ullrich A: Human proto-oncogene c-kit: A new cell surface receptor tyrosine kinase for an unidentified ligand. EMBO J 6:3341, 1987
55. Majumder S, Brown K, Qiu F-H, Besmer P: c-kit protein, a transmembrane kinase: Identification in tissues and characterization. Mol Cell Biol 8:4896, 1988
56. Blume-Jensen P, Claesson-Welsh L, Siegbahn A, Zsebo KM, Westermark B, Heldin C-H: Activation of the human c-kit product by ligand-induced dimerization mediates circular actin reorganization and chemotaxis. EMBO J 10:4121, 1991
57. Rosnet O, Bühring H-J, Marchetto S, Rappold I, Lavagna C, Sainty D, Arnoulet C, Chabannon C, Kanz L, Hannum C, Birnbaum D: Human FLT3/FLK2 receptor tyrosine kinase is expressed at the surface of normal and malignant hematoietic cells. Leukemia 10:238, 1996
58. Rose C, Rockwell P, Yang JQ, Pytowski B, Goldstein NI: Isolation and characterization of a monoclonal antibody binding to the extracellular domain of the flk-2 tyrosine kinase receptor. Hybridoma 14:453, 1995
59. Maroc N, Rottapel R, Rosnet O, Marchetto S, Lavezzi C, Mannoni P, Birnbaum D, Dubreuil P: Biochemical characterization and analysis of the transforming potential of the FLT3/FLK2 receptor tyrosine kinase. Oncogene 8:909, 1993
60. Broudy VC, Kovach NL, Bennett LG, Lin N, Jacobsen FW, Kidd PG: Human umbilical vein endothelial cells display high-affinity c-kit receptors and produce a soluble form of the c-kit receptor. Blood 83:2145, 1994
61. Broudy VC, Smith FO, Lin N, Zsebo KM, Egrie J, Bernstein ID: Blasts from patients with acute myelogenous leukemia express functional receptors for stem cell factor. Blood 80:60, 1992
62. Lev S, Yarden Y, Givol D: Dimerization and activation of the kit receptor by monovalent and bivalent binding of the stem cell factor. J Biol Chem 267:15970, 1992
63. Turner AM, Zsebo KM, Martin F, Jacobsen FW, Bennett LG, Broudy VC: Nonhematopoietic tumor cell lines express stem cell factor and display c-kit receptors. Blood 80:374, 1992
64. Turner AM, Bennett LG, Lin NL, Wypych J, Bartley TD, Hunt RW, Atkins HL, Langley KE, Parker V, Martin F, Broudy VC: Identification and characterization of a soluble c-kit receptor produced by human hematopoietic cell lines. Blood 85:2052, 1995
65. Turner AM, Lin NL, Issarachai S, Lyman SD, Broudy VC: FLT3 receptor expression on the surface of normal and malignant human hematopoietic cells. Blood 88:3383, 1996
66. Blechman JM, Lev S, Barg J, Eisenstein M, Vaks B, Vogel Z, Givol D, Yarden Y: The fourth immunoglobulin domain of the stem cell factor receptor couples ligand binding to signal transduction. Cell 80:103, 1995
67. Lemmon MA, Pinchasi D, Zhous M, Lax I, Schlessinger J: Kit receptor dimerization is driven by bivalent binding of stem cell factor. J Biol Chem 272:6311, 1997
68. Blechman JM, Lev S, Brizzi MF, Leitner O, Pegoraro L, Givol D, Yarden Y: Soluble c-kit proteins and antireceptor monoclonal antibodies confine the binding site of the stem cell factor. J Biol Chem 268:4399, 1993
69. Hsu Y, Wu G, Mendiaz EA, Syed R, Wypych J, Toso R, Mann MB, Boone TC, Narhi LO, Lu HS, Langley KE: The majority of stem cell factor exists as monomer under physiological conditions. J Biol Chem 272:6406, 1997
70. Lev S, Yarden Y, Givol D: A recombinant ectodomain of the receptor for the stem cell factor (SCF) retains ligand-induced receptor dimerization and antagonizes SCF-stimulated cellular responses. J Biol Chem 267:10866, 1992
71. Lev S, Givol D, Yarden Y: Interkinase domain of kit contains the binding site for phosphatidylinositol 3' kinase. Proc Natl Acad Sci USA 89:678, 1992
72. Reith AD, Ellis C, Lyman SD, Anderson DM, Williams DE, Bernstein A, Pawson T: Signal transduction by normal isoforms and W mutant variants of the Kit receptor tyrosine kinase. EMBO J 10:2451, 1991
73. Hayashi S-I, Kunisada T, Ogawa M, Yamaguchi K, Nishikawa S-I: Exon skipping by mutation of an authentic splice site of c-kit gene in W/W mouse. Nucleic Acids Res 19:1267, 1991
74. Crosier PS, Ricciardi ST, Hall LR, Vitas MR, Clark SC, Crosier KE: Expression of isoforms of the human receptor tyrosine kinase c-kit in leukemic cell lines and acute myeloid leukemia. Blood 82:1151, 1993
75. Piao X, Curtis JE, Minkin S, Minden MD, Bernstein A: Expression of the Kit and AitA receptor isoforms in human acute myelogenous leukemia. Blood 83:476, 1994
76. Wypych J, Bennett LG, Schwartz MG, Clogston CL, Lu HS, Broudy VC, Bartley TD, Parker VP, Langley KE: Soluble kit receptor in human serum. Blood 85:66, 1995
77. Lavagna C, Marchetto S, Birnbaum D, Rosnet O: Identification and characterization of a functional murine FLT3 isoform produced by exon skipping. J Biol Chem 270:3165, 1995
78. Bazan JF: Genetic and structural homology of stem cell factor and macrophage colony-stimulating factor. Cell 65:9, 1991
79. Anderson DM, Lyman SD, Baird A, Wignall JM, Eisenman J, Rauch C, March CJ, Boswell HS, Gimpel SD, Cosman D, Williams DE: Molecular cloning of mast cell growth factor, a hematopoietin that is active in both membrane bound and soluble forms. Cell 63:235, 1990
80. Arakawa T, Yphantis DA, Lary JW, Narhi LO, Lu HS, Prestrelski SJ, Clogston CL, Zsebo KM, Mendiaz EA, Wypych J, Langley KE: Glycosylated and unglycosylated recombinant-derived human stem cell factors are dimeric and have extensive regular secondary structure. J Biol Chem 266:18942, 1991
81. Lu HS, Clogston CL, Wypych J, Fausset PR, Lauren S, Mendiaz EA, Zsebo KM, Langley KE: Amino acid sequence and post-translational modification of stem cell factor isolated from buffalo rat liver cell-conditioned medium. J Biol Chem 266:8102, 1991
82. Pandit J, Bohm A, Jancarik J, Halenbeck R, Koths K, Kim S-H: Three-dimensional structure of dimeric human recombinant macrophage colony-stimulating factor. Science 258:1358, 1992
83. Nishikawa M, Tojo A, Ikebuchi K, Katayama K, Fujii N, Ozawa K, Asano S: Deletion mutagenesis of stem cell factor defines the C-terminal sequences essential for its biological activity. Biochem Biophys Res Commun 188:292, 1992
84. Langley KE, Mendiaz EA, Liu N, Narhi LO, Zeni L, Parseghian CM, Clogston CL, Leslie I, Pope JA, Lu HS, Zsebo KM: Properties of variant forms of human stem cell factor recombinantly expressed in Escherichia coli. Arch Biochem Biophys 311:55, 1994
85. Escobar S, Brasel K, Anderberg R, Lyman SD: Structure function studies of human flt3 ligand. Blood 86:21a, 1995 (abstr, suppl 1)
86. Zsebo KM, Wypych J, McNiece IK, Lu HS, Smith KA, Karkare SB, Sachdev RK, Yuschenkoff VN, Birkett NC, Williams LR, Satyagal VN, Tung W, Bosselman RA, Mendiaz EA, Langley KE: Identification, purification, and biological characterization of hemopoietic stem cell factor from buffalo rat liver-conditioned medium. Cell 63:195, 1990
87. Majumdar MK, Feng L, Medlock E, Toksoz D, Williams DA: Identification and mutation of primary and secondary proteolytic cleavage sites in murine stem cell factor cDNA yields biologically active, cell-associated protein. J Biol Chem 269:1237, 1994
88. d mutant. Cell 64:1025, 1991
89. Toksoz D, Zsebo KM, Smith KA, Hu S, Brankow D, Suggs SV, Martin FH, Williams DA: Support of human hematopoiesis in long-term bone marrow cultures by murine stromal cells selectively expressing the membrane-bound and secreted forms of the human homolog of the steel gene product, stem cell factor. Proc Natl Acad Sci USA 89:7350, 1992
90. Huang EJ, Nocka KH, Buck J, Besmer P: Differential expression and processing of two cell associated forms of the kit-ligand: KL-1 and KL-2. Mol Biol Cell 3:349, 1992
91. Lyman SD, Williams DE: Biological control of mast cell growth factor c-kit interactions may be mediated through alternate splicing of mRNAs, in Murphy MJ Jr (eds): Blood Cell Growth Factors: Their Present and Future Use in Hematology and Oncology. Proceedings of the Beijing Symposium, August 21-24, 1991. Dayton, OH, AlphaMed, 1991, p 183
92. Brannan CI, Lyman SD, Williams DE, Eisenman J, Anderson DM, Cosman D, Bedell MA, Jenkins NA, Copeland NG: Steel-Dickie mutation encodes a c-Kit ligand lacking transmembrane and cytoplasmic domains. Proc Natl Acad Sci USA 88:4671, 1991
93. Cerretti DP, Wignall J, Anderson D, Tushinski RJ, Gallis BM, Stya M, Gillis S, Urdal DL, Cosman D: Human macrophage-colony stimulating factor: Alternative RNA and protein processing from a single gene. Mol Immunol 25:761, 1988
94. Lyman SD, James L, Escobar S, Downey H, de Vries P, Brasel K, Stocking K, Beckmann MP, Copeland NG, Cleveland LS, Jenkins NA, Belmont JW, Davison BL: Identification of soluble and membrane-bound isoforms of the murine flt3 ligand generated by alternative splicing of mRNAs. Oncogene 10:149, 1995
95. Lyman SD, Stocking K, Davison B, Fletcher F, Johnson L, Escobar S: Structural analysis of human and murine flt3 ligand genomic loci. Oncogene 11:1165, 1995
96. Agnès F, Shamoon B, Dina C, Rosnet O, Birnbaum D, Galibert F: Genomic structure of the downstream part of the human FLT3 gene: Exon/intron structure conservation among genes encoding receptor tyrosine kinases (RTK) of subclass III. Gene 145:283, 1994
97. Gokkel E, Grossman Z, Ramot B, Yarden Y, Rechavi G, Givol D: Structural organization of the murine c-kit proto-oncogene. Oncogene 7:1423, 1992
98. André C, Martin E, Cornu F, Hu W-X, Wang X-P, Galibert F: Genomic organization of the human c-kit gene: Evolution of the receptor tyrosine kinase subclass III. Oncogene 7:685, 1992
99. Vandenbark GR, deCastro CM, Taylor H, Dew-Knight S, Kaufman RE: Cloning and structural analysis of the human c-kit gene. Oncogene 7:1259, 1992
100. Giebel LB, Strunk KM, Holmes SA, Spritz RA: Organization and nucleotide sequence of the human KIT (mast/stem cell growth factor receptor) proto-oncogene. Oncogene 7:2207, 1992
101. Imbert A, Rosnet O, Marchetto S, Ollendorff V, Birnbaum D, Pebusque MJ: Characterization of a yeast artificial chromosome from human chromosome band 13q12 containing the FLT1 and FLT3 receptor-type tyrosine kinase genes. Cytogenet Cell Genet 67:175, 1994
102. Wang Z, Kim E, Chinault AC, Civin CI, Small D: Genomic organization of the human Stk-1 (flt3/flk2) gene. Blood 88:111b, 1996 (abstr, suppl 1)
103. 17H mice result from a splicing defect in the steel factor cytoplasmic tail. Genes Dev 6:1832, 1992
104. Ladner MB, Martin GA, Noble JA, Nikoloff DM, Tal R, Kawasaki ES, White TJ: Human CSF-1: Gene structure and alternative splicing of mRNA precursors. EMBO J 6:2693, 1987
105. Rosnet O, Stephenson D, Mattei M-G, Marchetto S, Shibuya M, Chapman VM, Birnbaum D: Close physical linkage of the FLT1 and FLT3 genes on chromosome 13 in man and chromosome 5 in mouse. Oncogene 8:173, 1993
106. Shibuya M, Yamaguchi S, Yamane A, Ikeda T, Tojo A, Matsushime H, Sato M: Nucleotide sequence and expression of a novel human receptor-type tyrosine kinase gene (fit) closely related to the fms family. Oncogene 5:519, 1990
107. d'Auriol L, Mattei MG, Andre C, Galibert F: Localization of the human c-kit protooncogene on the q11-q12 region of chromosome 4. Hum Genet 78:374, 1988
108. Geissler EN, Liao M, Brook JD, Martin FH, Zsebo KM, Housman DE, Galli SJ: Stem cell factor (SCF), a novel hematopoietic growth factor and ligand for c-kit tyrosine kinase receptor, maps on human chromosome 12 between 12q14.3 and 12qter. Somat Cell Mol Genet 17:207, 1991
109. McClanahan T, Culpepper J, Campbell D, Wagner J, Franz-Bacon K, Mattson J, Tsai S, Luh J, Guimaraes MJ, Mattei M-G, Rosnet O, Birnbaum D, Hannum CH: Biochemical and genetic characterization of multiple splice variants of the Flt3 ligand. Blood 88:3371, 1996
110. Ezoe K, Holmes SA, Ho L, Bennett CP, Bolognia JL, Brueton L, Burn J, Falabella R, Gatto EM, Ishii N, Moss C, Pittelkow MR, Thompson E, Ward KA, Spritz RA: Novel mutations and deletion of the KIT (steel factor receptor) gene in human piebaldism. Am J Hum Genet 56:58, 1995
111. Keller SA, Liptay S, Hajra A, Meisler MH: Transgene-induced mutation of the murine steel locus. Proc Natl Acad Sci USA 87:10019, 1990
112. Bedell MA, Brannan CI, Evans EP, Copeland NG, Jenkins NA, Donovan PJ: DNA rearrangements located over 100 kb 5' of the Steel (Sl)-coding region in Steel-panda and Steel-contrasted mice deregulate Sl expression and cause female sterility by disrupting ovarian follicle development. Genes Dev 9:455, 1995
113. Johansson B, Billstrom R, Mauritzson N, Mitelman F: Trisomy 19 as the sole chromosomal anomaly in hematologie neoplasms. Cancer Genet Cytogenet 74:62, 1994
114. Keshet E, Lyman SD, Williams DE, Anderson DM, Jenkins NA, Copeland NG, Parada LF: Embryonic RNA expression patterns of the c-kit receptor and its cognate ligand suggest multiple functional roles in mouse development. EMBO J 10:2425, 1991
115. Matsui Y, Zsebo KM, Hogan BLM: Embryonic expression of a haematopoietic growth factor encoded by the Sl locus and the ligand for c-kit. Nature 347:667, 1990
116. Motro B, van der Kooy D, Rossant J, Reith A, Bernstein A: Contiguous patterns of c-kit and steel expression: analysis of mutations at the W and Sl loci. Development 113:1207, 1991
117. Aye MT, Hashemi S, Leclair B, Zeibdawi A, Trudel E, Halpenny M, Fuller V, Cheng G: Expression of stem cell factor and c-kit mRNA in cultured endothelial cells, monocytes and cloned human bone marrow stromal cells (CFU-RF). Exp Hematol 20:523, 1992
118. McNiece IK, Langley KE, Zsebo KM: The role of recombinant stem cell factor in early B cell development. Synergistic interaction with IL-7. J Immunol 146:3785, 1991
119. Flanagan JG, Leder P: The kit ligand: A cell surface molecule altered in Steel mutant fibroblasts. Cell 63:185, 1990
120. deLapeyriere O, Naquet P, Planche J, Marchetto S, Rottapel R, Gambarelli D, Rosnet O, Birnbaum D: Expression of Flt3 tyrosine kinase receptor gene in mouse hematopoietic and nervous tissues. Differentiation 58:351, 1995
121. Hu ZB, Ma W, Uphoff CC, Quentmeier H, Drexler HG: c-kit expression in human megakaryoblastic leukemia cell lines. Blood 83:2133, 1994
122. André C, d'Auriol L, Lacombe C, Gisselbrecht S, Galibert F: c-kit mRNA expression in human and murine hematopoietic cell lines. Oncogene 4:1047, 1989
123. Da Silva N, Hu ZB, Ma W, Rosnet O, Birnbaum D, Drexler HG: Expression of the FLT3 gene in human leukemia-lymphoma cell lines. Leukemia 8:885, 1994
124. Wang C, Curtis JE, Geissler EN, McCulloch EA, Minden MD: The expression of the proto-oncogene C-kit in the blast cells of acute myeloblastic leukemia. Leukemia 3:699, 1989
125. Monta S, Tsuchiya S, Fujie H, Itano M, Ohashi Y, Minegishi M, Imaizumi M, Endo M, Takano N, Konno T: Cell surface c-kit receptors in human leukemia cell lines and pediatric leukemia: Selective preservation of c-kit expression on megakaryoblastic cell lines during adaptation to in vitro culture. Leukemia 10:102, 1996
126. - (triple-negative) thymocytes. Exp Hematol 22:1025, 1994
127. Moriyama Y, Tsujimura T, Hashimoto K, Morimoto M, Kitayama H, Matsuzawa, Kitamura Y, Kanakura Y: Role of aspartic acid 814 in the function and expression of c-kit receptor tyrosine kinase. J Biol Chem 271:3347, 1996
128. Hjeitson M, Sundström C, Lyman SD, Nilsson K, Nilsson G: Stem cell factor, but not flt3 ligand, induces differentiation and activation of human mast cells. Exp Hematol 24:748, 1996
129. Brasel K, Escobar S, Anderberg R, de Vries P, Gruss H-J, Lyman SD: Expression of the flt3 receptor and its ligand on hematopoietic cells. Leukemia 9:1212, 1995
130. Meierhoff G, Dehmel U, Gruss H-J, Rosnet O, Birnbaum D, Quentmeier H, Dirks W, Drexler HG: Expression of flt3 receptor and flt3-ligand in human leukemia-lymphoma cell lines. Leukemia 9:1368, 1995
131. Ikeda H, Kanakura Y, Tamaki T, Kuriu A, Kitayama H, Ishikawa J, Kanayama Y, Yonezawa T, Tarui S, Griffin JD: Expression and functional role of the proto-oncogene c-kit in acute myeloblastic leukemia cells. Blood 78:2962, 1991
132. Lerner NB, Nocka KH, Cole SR, Qiu FH, Strife A, Ashman LK, Besmer P: Monoclonal antibody YB5.B8 identifies the human c-kit protein product. Blood 77:1876, 1991
133. Kubota A, Okamura S, Shimoda K, Harada M, Niho Y: The c-kit molecule and the surface immunophenotype of human acute leukemia. Leuk Lymphoma 14:421, 1994
134. Reuss-Borst MA, Buhring HJ, Schmidt H, Muller CA: AML: Immunophenotypic heterogeneity and prognostic significance of c-kit expression. Leukemia 8:258, 1994
135. Kanakura Y, Ikeda H, Kitayama H, Sugahara H, Furitsu T: Expression, function and activation of the proto-oncogene c-kit product in human leukemia cells. Leuk Lymphoma 10:35, 1993
136. Lauria F, Bagnara GP, Rondelli D, Raspadori D, Strippoli P, Bonsi L, Ventura MA, Montanaro LL, Bubola G, Tura S, Broudy VC: Cytofluorimetric and functional analysis of c-kit receptor in acute leukemia. Leuk Lymphoma 18:451, 1995
137. Carlesso N, Pregno P, Bresso P, Gallo E, Pileri A, Zsebo KM, Ferrero D: Human recombinant stem cell factor stimulates in vitro proliferation of acute myeloid leukemia cells and expands the clonogenic cell pool. Leukemia 6:642, 1992
138. Goselink HM, Williams DE, Fibbe WE, Wessels HW, Beverstock GC, Willemze R, Falkenburg JH: Effect of mast cell growth factor (c-kit ligand) on clonogenic leukemic precursor cells. Blood 80:750, 1992
139. Valverde LR, Matutes E, Farahat N, Heffernan A, Owusu-Ankomah K, Morilla R, Catovsky D: C-kit receptor (CD117) expression in acute leukemia. Ann Hematol 72:11, 1996
140. Cole SR, Aylett GW, Harvey NL, Cambareri AC, Ashman LK: Increased expression of c-kit or its ligand Steel factor is not a common feature of adult acute myeloid leukaemia. Leukemia 10:288, 1996
141. Drexler HG: Expression of FLT3 receptor and response to FLT3 ligand by leukemic cells. Leukemia 10:588, 1996
142. McKenna HJ, Smith FO, Brasel K, Hirschstein D, Bernstein ID, Williams DK, Lyman SD: Effects of flt3 ligand on acute myeloid and lymphocytic leukemic blast cells from children. Exp Hematol 24:378, 1996
143. Carow CE, Levenstein M, Kaufmann SH, Chen J, Amin S, Rockwell P, Witte L, Borowitz MJ, Civin CI, Small D: Expression of the hematopoietic growth factor receptor FLT3 (STK-1/Flk2) in human leukemias. Blood 87:1089, 1996
144. Birg F, Courcoul M, Rosnet O, Bardin F, Pébusque M-J, Marchetto S, Tabilio A, Mannoni P, Birnbaum D: Expression of the FMS/KIT-like gene FLT3 in human acute leukemias of the myeloid and lymphoid lineages. Blood 80:2584, 1992
145. Stacchini A, Fubini L, Severino A, Sanavio F, Aglietta M, Piacibello W: Expression of type III receptor tyrosine kinases FLT3 and KIT and responses to their ligands by acute myeloid leukemia blasts. Leukemia 10:1584, 1996
146. Piacibello W, Fubini L, Sanavio F, Brizzi MF, Severino A, Garetto L, Stacchini A, Pegoraro L, Aglietta M: Effects of human FLT3 ligand on myeloid leukemia cell growth: Heterogeneity in response and synergy with other hematopoietic growth factors. Blood 86:4105, 1995
147. + anaplastic large cell lymphomas. Blood 83:785, 1994
148. Kiyoi H, Naoe T, Yokota S, Nakao M, Minami S, Kuriyama K, Takeshita A, Saito K, Hasegawa S, Shimodaira S, Tamura J, Shimazaki C, Matsue K, Kobayashi H, Arima N, Suzuki R, Morishita H, Saito H, Ueda R, Ohno R: Internal tandem duplication of FLT3 associated with leukocytosis in acute promyelocytic leukemia. Leukemia 11:1447, 1997
149. Horiike S, Yokota S, Nakao M, Iwai T, Sasai Y, Kaneko H, Taniwaki M, Kashima K, Fujii H, Abe T, Misawa S: Tandem duplications of the FLT3 receptor gene are associated with leukemic transformation of myelodysplasia. Leukemia 11:1442, 1997
150. Buhring HJ, Ullrich A, Schaudt K, Muller CA, Busch FW: The product of the proto-oncogene c-kit (P145c-kit) is a human bone marrow surface antigen of hemopoietic precursor cells which is expressed on a subset of acute non-lymphoblastic leukemic cells. Leukemia 5:854, 1991
151. Muroi K, Nakamura M, Amemiya Y, Suda T, Miura Y: Expression of c-kit receptor (CD117) and CD34 in leukemic cells. Leuk Lymphoma 16:297, 1995
152. Carson WE, Haldar S, Baiocchi RA, Croce CM, Caligiuri MA: The c-kit ligand suppresses apoptosis of human natural killer cells through the upregulation of bcl-2. Proc Natl Acad Sci USA 91:7553, 1994
153. Lisovsky M, Estrov Z, Zhang X, Consoli U, Sanchez-Williams G, Snell V, Munker R, Goodacre A, Savchenko V, Andreeff M: Flt3 ligand stimulates proliferation and inhibits apoptosis of acute myeloid leukemia cells: Regulation of Bcl-2 and Bax. Blood 88:3987, 1996
154. Wang C, Koistinen P, Yang GS, Williams DE, Lyman SD, Minden MD, McCulloch EA: Mast cell growth factor, a ligand for the receptor encoded by c-kit, affects the growth in culture of the blast cells of acute myeloblastic leukemia. Leukemia 5:493, 1991
155. Hassan HT, Zander A: Stem cell factor as a survival and growth factor in human normal and malignant hematopoiesis. Acta Haematol 95:257, 1996
156. Pietsch T, Kyas U, Steffens U, Yakisan E, Hadam MR, Ludwig WD, Zsebo K, Welte K: Effects of human stem cell factor (c-kit ligand) on proliferation of myeloid leukemia cells: Heterogeneity in response and synergy with other hematopoietic growth factors. Blood 80:1199, 1992
157. Agarwal R, Doren S, Hicks B, Dunbar CE: Long-term culture of chronic myelogenous leukemia marrow cells on stem cell factor-deficient stroma favors benign progenitors. Blood 85:1306, 1995
158. Mahon FX, Pigeonnier V, Chahine H, Barbot C, Jazwiec B, Ripoche J, Reiffers J: Flt3 ligand preferentially stimulates normal immature progenitor (Philadelphia negative) in chronic myeloid leukemia (CML). Blood 88:234a, 1996 (abstr, suppl 1)
159. Eder M, Hemmati P, Kalina U, Ottmann OG, Hoelzer D, Lyman SD, Ganser A: Effects of Flt3 ligand and interleukin-7 on in vitro growth of acute lymphoblastic leukemia cells. Exp Hematol 24:371, 1996
160. Fukuda T, Kamishima T, Tsuura Y, Suzuki T, Kakihara T, Naito M, Kishi K, Matsumoto K, Shibata A, Seito T: Expression of the c-kit gene product in normal and neoplastic mast cells but not in neoplastic basophil/mast cell precursors from chronic myelogenous leukemia. J Pathol 177:139, 1995
161. Tsujimura T, Furitsu T, Morimoto M, Kanayama Y, Nomura S, Matsuzawa Y, Kitamura Y, Kanakura Y: Substitution of an aspartic acid results in constitutive activation of c-kit receptor tyrosine kinase in a rat tumor mast cell line RBL-2H3. Int Arch Allergy Immunol 106:377, 1995
162. Metcalf D, Nicola NA: Direct proliferative actions of stem cell factor on murine bone marrow cells in vitro: Effects of combination with colony-stimulating factors. Proc Natl Acad Sci USA 88:6239, 1991
163. Rolink A, Ghia P, Grawunder U, Haasner D, Karasuyama H, Kalberer C, Winkler T, Melchers F: In-vitro analyses of mechanisms of B-cell development. Semin Immunol 7:155, 1995
164. Rico-Vargas SA, Weiskopf B, Nishikawa S, Osmond DG: c-kit expression by B cell precursors in mouse bone marrow. Stimulation of B cell genesis by in vivo treatment with anti-c-kit antibody. J Immunol 152:2845, 1994
165. Moore TA, Zlotnik A: T-cell lineage commitment and cytokine responses of thymic progenitors. Blood 86:1850, 1995
166. Rasko JEJ, Metcalf D, Rossner MT, Begley CG, Nicola NA: The flt3/flk-2 ligand: receptor distribution and action on murine haemopoietic cell survival and proliferation. Leukemia 9:2058, 1995
167. Hunt P, Zsebo KM, Hokom MM, Homkohl A, Birkett NC, del Castillo JC, Martin F: Evidence that stem cell factor is involved in the rebound thrombocytosis that follows 5-fluorouracil treatment. Blood 80:904, 1992
168. Avraham H, Vannier E, Cowley S, Jiang SX, Chi S, Dinarello CA, Zsebo KM, Groopman JE: Effects of the stem cell factor, c-kit ligand, on human megakaryocytic cells. Blood 79:365, 1992
169. Ratajczak MZ, Ratajczak J, Ford J, Kregenow R, Marlicz W, Gewirtz AM: FLT3/FLK-2 (STK-1) ligand does not stimulate human megakaryopoiesis in vitro. Stem Cells 14:146, 1996
170. Grabarek J, Groopman JE, Lyles YR, Jiang S, Bennett L, Zsebo K, Avraham H: Human kit ligand (stem cell factor) modulates platelet activation in vitro. J Biol Chem 269:21718, 1994
171. Wasserman R, Li YS, Hardy RR: Differential expression of the blk and ret tyrosine kinases during B lineage development is dependent on Ig rearrangement. J Immunol 155:644, 1995
172. Papayannopoulou T, Brice M, Broudy VC, Zsebo KM: Isolation of c-kit receptor-expressing cells from bone marrow, peripheral blood, and fetal liver: Functional properties and composite antigenic profile. Blood 78:1403, 1991
173. Ashman LK, Cambareri AC, To LB, Levinsky RJ, Juttner CA: Expression of the YB5.B8 antigen (c-kit proto-oncogene product) in normal human bone marrow. Blood 78:30, 1991
174. Broudy VC, Lin N, Zsebo KM, Birkett NC, Smith KA, Bernstein ID, Papayannopoulou T: Isolation and characterization of a monoclonal antibody that recognizes the human c-kit receptor. Blood 79:338, 1992
175. Matos ME, Schnier GS, Beecher MS, Ashman LK, William DE, Caligiuri MA: Expression of a functional c-kit receptor on a subset of natural killer cells. J Exp Med 178:1079, 1993
176. Rappold I, Ziegler BL, Köhler I, Marchetto S, Rosnet O, Birnbaum D, Simmons PJ, Zannettino ACW, Hill B, Neu S, Knapp W, Alitalo R, Alitalo K, Ullrich A, Kanz L, Büring HJ: Functional and phenotypic characterization of cord blood and bone marrow subsets expressing FLT3 (CD135) receptor tyrosine kinase. Blood 90:111, 1997
177. Tsai M, Takeishi T, Thompson H, Langley KE, Zsebo KM, Metcalfe DD, Geissler EN, Galli SJ: Induction of mast cell proliferation, maturation and heparin synthesis by rat c-kit ligand, stem cell factor. Proc Natl Acad Sci USA 88:6382, 1991
178. Galli SJ, Iemura A, Garlick DS, Gamba-Vitalo C, Zsebo KM, Andrews RG: Reversible expansion of primate mast cell populations in vivo by stem cell factor. J Clin Invest 91:148, 1993
179. Costa JJ, Demetri GD, Hayes DF, Merica EA, Menchaca DM, Galli SJ: Increased skin mast cells and urine methyl histamine in patients receiving recombinant methionyl human stem cell factor. Proc Am Assoc Cancer Res 34:211, 1993
180. Lynch DH, Jacobs C, DuPont D, Eisenman J, Foxworthe D, Martin U, Miller RE, Roux E, Liggitt D, Williams DE: Pharmacokinetic parameters of recombinant mast cell growth factor (rMGF). Lymphokine Cytokine Res 11:233, 1992
181. Moskowitz CH, Stiff P, Gordon MS, McNiece I, Ho AD, Costa JJ, Broun ER, Bayer RA, Wyres M, Hill J, Jelaca-Maxwell K, Nichols CR, Brown SL, Nimer SD, Gabrilove J: Recombinant methionyl human stem cell factor and filgrastim for peripheral blood progenitor cell mobilization and transplantation in non-Hodgkins lymphoma patients-Results of a phase I/II trial. Blood 89:3136, 1997
182. Demetri G, Costa J, Hayes D, Sledge G, Galli S, Hoffman R, Merica E, Rich W, Harkins B, McGuire B, Gordon M: A phase I trial of recombinant methionyl human stem cell factor (SCF) in patients with advanced breast carcinoma pre-and post-chemotherapy with cyclophosphamide and doxorubicin. Proc Am Assoc Clin Oncol 12:A367, 1993
183. Ogawa M, Matsuzaki Y, Nishikawa S, Hayashi S-I, Kunisada T, Sudo T, Kina T, Nakauchi H, Nishikawa S-I: Expression and function of c-kit in hemopoietic progenitor cells. J Exp Med 174:63, 1991
184. Okada S, Nakauchi H, Nagayoshi K, Nishikawa S-I, Miura Y, Suda T: In vivo and in vitro stem cell function of c-kit-and Sea-1-positive murine hematopoietic cells. Blood 80:3044, 1992
185. Okada S, Nakauchi H, Nagayoshi K, Nishikawa S, Nishikawa S, Miura Y, Suda T: Enrichment and characterization of murine hematopoietic stem cells that express c-kit molecule. Blood 78:1706, 1991
186. Ikuta K, Weissman IL: Evidence that hematopoietic stem cells express mouse c-kit but do not depend on steel factor for their generation. Proc Natl Acad Sci USA 89:1502, 1992
187. Orlic D, Fischer R, Nishikawa S, Nienhuis AW, Bodine DM: Purification and characterization of heterogeneous pluripotent hematopoietic stem cell populations expressing high levels of c-kit receptor. Blood 82:762, 1993
188. Li CL, Johnson GR: Murine hematopoietic stem and progenitor cells: I. Enrichment and biologic characterization. Blood 85:1472, 1995
189. Simmons PJ, Aylett GW, Niutta S, To LB, Juttner CA, Ashman LK: c-kit is expressed by primitive human hematopoietic cells that give rise to colony-forming cells in stroma-dependent or cytokine-supplemented culture. Exp Hematol 22:157, 1994
190. Olweus J, Terstappen LW, Thompson PA, Lund-Johansen F: Expression and function of receptors for stem cell factor and erythropoietin during lineage commitment of human hematopoietic progenitor cells. Blood 88:1594, 1996
191. Briddell RA, Broudy VC, Bruno E, Brandt JE, Srour EF, Hoffman R: Further phenotypic characterization and isolation of human hematopoietic progenitor cells using a monoclonal antibody to the c-kit receptor. Blood 79:3159, 1992
192. Gabbianelli M, Pelosi E, Montesoro E, Valtieri M, Luchetti L, Samoggia P, Vitelli L, Barben T, Testa U, Lyman S, Peschle C: Multi-level effects of flt3 ligand on human hematopoiesis: Expansion of putative stem cells and proliferation of granulomonocytic progenitors/ monocytic precursors. Blood 86:1661, 1995
193. Saraya K, Reid CD: Stem cell factor and the regulation of dendritic cell production from CD34+ progenitors in bone marrow and cord blood. Br J Haematol 93:258, 1996
194. Szabolcs P, Moore MAS, Young JW: Expansion of immunostimulatory dendritic cells among the myeloid progeny of human CD34+ bone marrow precursors cultured with c-kit ligand, granulocyte-macrophage colony-stimulating factor, and TNF-α. J Immunol 154: 5851, 1995
195. + hematopoietic precursor cells. Blood 87:535, 1996
196. + bone marrow. Blood 86:420a, 1995 (abstr, suppl 1)
197. Broxmeyer HE, Hangoc G, Cooper S, Anderson D, Cosman D, Lyman SD, Williams DE: Influence of murine mast cell growth factor (c-kir ligand) on colony formation by mouse marrow hematopoietic progenitor cells. Exp Hematol 19:143, 1991
198. Xiao M, Leemhuis T, Broxmeyer HE, Lu L: Influence of combinations of cytokines on proliferation of isolated single cell-sorted human bone marrow hematopoietic progenitor cells in the absence and presence of serum. Exp Hematol 20:276, 1992
199. Broxmeyer HE, Cooper S, Lu L, Hangoc G, Anderson D, Cosman D, Lyman SD, Williams DE: Effect of murine mast cell growth factor (c-kit proto-oncogene ligand) on colony formation by human marrow hematopoietic progenitor cells. Blood 77:2142, 1991
200. McNiece IK, Langley KE, Zsebo KM: Recombinant human stem cell factor synergizes with GM-CSF, G-CSF, IL-3 and Epo to stimulate human progenitor cells of the myeloid and the erythroid lineages. Blood 19:226, 1991
201. Uoshima N, Ozawa M, Kimura S, Tanaka K, Wada K, Kobayashi Y, Kondo M: Changes in c-Kit expression and effects of SCF during differentiation of human erythroid progenitor cells. Br J Haematol 91:30, 1995
202. + cells. J Exp Med 183:837, 1996
203. Wu H, Klingmuller U, Besmer P, Lodish HF: Interaction of the erythropoietin and stem cell factor receptors. Nature 377:242, 1995
204. + hematopoietic progenitors. Blood 88:1168, 1996
205. Jacobsen SEW, Okkenhaug C, Myklebust J, Veiby OP, Lyman SD: The FLT3 ligand potently and directly stimulates the growth and expansion of primitive murine bone marrow progenitor cells in vitro: synergistic interactions with interleukin (IL) 11, IL-12, and other hematopoietic growth factors. J Exp Med 181:1357, 1995
206. Hudak S, Hunte B, Culpepper J, Menon S, Hannum C, Thompson-Snipes L, Rennick D: FLT3/FLK2 ligand promotes the growth of murine stem cells and the expansion of colony-forming cells and spleen colony-forming units. Blood 85:2747, 1995
207. + bone marrow progenitor cells in vitro. Blood 87:1317, 1996
208. + hematopoietic progenitor cells. Blood 86:3413, 1995
209. d mice. Blood 42:865, 1973
210. d bone marrow. Exp Hematol 12:237, 1984
211. Ebbe S, Bentfeld-Barker M, Adrados C, Carpenter D, Mortensen C, Yee T, Phalen E: Functionally abnormal stromal cells and megakaryocyte size, ploidy, and ultrastructure in Sl/Sld mice. Blood Cells 12:217, 1986
212. Briddell RA, Bruno E, Cooper RJ, Brandt JE, Huffman R: Effect of c-kit ligand on in vitro human megakaryocytopoiesis. Blood 78:2854, 1991
213. Tanaka R, Koike K, Imai T, Shiohara M, Kubo T, Amano Y, Komiyama A, Nakahata T: Stem cell factor enhances proliferation, but not maturation, of murine megakaryocytic progenitors in serum-free culture. Blood 80:1743, 1992
214. + cells. Blood 82:84, 1993
215. Imai T, Nakahata T: Stem cell factor promotes proliferation of human primitive megakaryocytic progenitors, but not megakaryocytic maturation. Int J Hematol 59:91, 1994
216. Burstein SA, Henthorn J, Mei R, Williams DE: Mast cell growth factor (MGF) promotes human and murine megakaryocytic (MK) differentiation in vitro. Blood 78:160a, 1991 (abstr, suppl 1)
217. Kaushansky K: Thrombopoietin: The primary regulator of platelet production. Blood 86:419, 1995
218. Nichol JL, Hokom MM, Homkohl A, Sheridan WP, Ohashi H, Kato T, Li YS, Bartley TD, Choi E, Bogenberger J, Skrine JD, Knudten A, Chen J, Trail G, Sleeman L, Cole S, Grampp G, Hunt P: Megakaryocyte growth and development factor. Analyses of in vitro effects on human megakaryocytopoiesis and endogenous serum levels during chemotherapy-induced thrombocytopenia. J Clin Invest 95: 2973, 1995
219. Broudy VC, Lin NL, Kaushansky K: Thrombopoietin (c-mpl ligand) acts synergistically with erythropoietin, stem cell factor, and interleukin-11 to enhance murine megakaryocyte colony growth and increases megakaryocyte ploidy in vitro. Blood 85:1719, 1995
220. Hunt P, Li YS, Nichol JL, Hokom MM, Bogenberger JM, Swift SE, Skrine JD, Homkohl AC, Lu H, Clogston C, Merewether LA, Johnson MJ, Parker V, Knudten A, Farese A, Hsu RY, Garcia A, Stead R, Bosselman RA, Bartley TD: Purification and biologic characterization of plasma-derived megakaryocyte growth and development factor. Blood 86:540, 1995
221. Banu N, Wang JF, Deng B, Groopman JE, Avraham H: Modulation of megakaryocytopoiesis by thrombopoietin: The c-Mpl ligand. Blood 86:1331, 1995
222. Ku H, Yonemura Y, Kaushansky K, Ogawa M: Thrombopoietin, the ligand for the Mpl receptor, synergizes with steel factor and other early acting cytokines in supporting proliferation of primitive hematopoietic progenitors of mice. Blood 87:4544, 1996
223. Ramsfjell V, Borge OJ, Veiby OP, Cardier J, Murphy MJ Jr, Lyman SD, Lok S, Jacobsen SEW: Thrombopoietin, but not erythropoietin, directly stimulates multilineage growth of primitive murine bone marrow progenitor cells in synergy with early acting cytokines: distinct interactions with the ligands for c-kit and FLT3. Blood 88:4481, 1996
224. -) human bone marrow progenitor cells: Distinct and key interactions with the ligands for c-kit and flt3, and inhibitory effects of TGF-β and TNF-α. J Immunol 158:5169, 1997
225. Sitnicka E, Lin N, Priestley GV, Fox N, Broudy VC, Wolf NS, Kaushansky K: The effect of thrombopoietin on the proliferation and differentiation of murine hematopoietic stem cells. Blood 87:4998, 1996
226. Kobayashi M, Laver JH, Kato T, Miyazaki H, Ogawa M: Thrombopoietin supports proliferation of human primitive hematopoietic cells in synergy with steel factor and/or interleukin-3. Blood 88:429, 1996
227. Mackarehtschian K, Hardin JD, Moore KA, Boast S, Goff SP, Lemischka IR: Targeted disruption of the flk2/flt3 gene leads to deficiencies in primitive hematopoietic progenitors. Immunity 3:147, 1995
228. Piacibello W, Garetto L, Sanavio F, Severine A, Fubini L, Stacchini A, Dragonetti G, Aglietta M: The effects of human FLT3 ligand on in vitro human megakaryocytopoiesis. Exp Hematol 24:340, 1996
229. Piacibello W, Sanavio F, Garetto L, Severino A, Bergandi D, Ferrario J, Fagioli F, Berger M, Aglietta M: Extensive amplification and self-renewal of human primitive hematopoietic stem cells from cord blood. Blood 89:2644, 1997
230. Henderson AJ, Narayanan R, Collins L, Dorshkind K: Status of κL chain gene rearrangements and c-kit and IL-7 receptor expression in stromal cell-dependent pre-B cells. J Immunol 149:1973, 1992
231. Faust EA, Saffran DC, Toksoz D, Williams DA, Witte ON: Distinctive growth requirements and gene expression patterns distinguish progenitor B cells from pre-B cells. J Exp Med 177:915, 1993
232. Hozumi K, Kobori A, Sato T, Nozaki H, Nishikawa S, Nishimura T, Habu S: Pro-T cells in fetal thymus express c-kit and RAG-2 but do not rearrange the gene encoding the T cell receptor beta chain. Eur J Immunol 24:1339, 1994
233. Godfrey DI, Zlotnik A, Suda T: Phenotypic and functional characterization of c-kit expression during intrathymic T cell development. J Immunol 149:2281, 1992
234. - thymocyte differentiation. J Immunol 152: 4783, 1994
235. Godfrey DI, Kennedy J, Gately MK, Hakimi J, Hubbard BR, Zlotnik A: IL-12 influences intrathymic T cell development. J Immunol 152:2729, 1994
236. Dehmel U, Quentmeier H, Drexler HG: Effects of FLT3 ligand on human leukemia cells. II. Agonistic and antagonistic effects of other cytokines. Leukemia 10:271, 1996
237. Wu L, Vremec D, Ardavin C, Winkel K, Süss G, Georgiou H, Maraskovsky E, Cook W, Shortman K: Mouse thymus dendritic cells: Kinetics of development and changes in surface markers during maturation. Eur J Immunol 25:418, 1995
238. Landreth KS, Kincade PW, Lee G, Harrison DE: B lymphocyte precursors in embryonic and adult W anemic mice. J Immunol 132:2724, 1984
239. Billips LG, Petitte D, Dorshkind K, Narayanan R, Chiu C-P, Landreth KS: Differential roles of stromal cells, interleukin-7, and kit-ligand in the regulation of B lymphopoiesis. Blood 79:1185, 1992
240. Funk PE, Varas A, Witte PL: Activity of stem cell factor and IL-7 in combination on normal bone marrow B lineage cells. J Immunol 150:748, 1993
241. Relink A, Streb M, Nishikawa S-I, Melchers F: The c-kit-encoded tyrosine kinase regulates the proliferation of early pre-B cells. Eur J Immunol 21:2609, 1991
242. Palacios R, Samaridis J: Fetal liver pro-B and pre-B lymphocyte clones: Expression of lymphoid-specific genes, surface markers, growth requirements, colonization of the bone marrow, and generation of B lymphocytes in vivo and in vitro. Mol Cell Biol 12:518, 1992
243. Hirayama F, Shih JP, Awgulewitsch A, Warr GW, Clark SC, Ogawa M: Clonal proliferation of murine lymphohemopoietic progenitors in culture. Proc Natl Acad Sci USA 89:5907, 1992
244. Ball TC, Hirayama F, Ogawa M: Lymphohematopoietic progenitors of normal mice. Blood 85:3086, 1995
245. Hirayama F, Lyman SD, Clark SC, Ogawa M: The flt3 ligand supports proliferation of lymphohematopoietic progenitors and early B-lymphoid progenitors. Blood 85:1762, 1995
246. Kee BL, Cumano A, Iscove NN, Paige CJ: Stromal cell independent growth of bipotent B cell-macrophage precursors from murine fetal liver. Int Immunol 6:401, 1994
247. Takeda S, Shimizu T, Rodewald HR: Interactions between c-kit and stem cell factor are not required for B-cell development in vivo. Blood 89:518, 1997
248. McKenna HJ, Miller RE, Brasel KE, Maraskovsky E, Maliszewski C, Pulendran B, Lynch D, Teepe M, Roux ER, Smith J, Williams DE, Lyman SD, Peschon JJ, Stocking K: Targeted disruption of the flt3 ligand gene in mice affects multiple hematopoietic lineages, including natural killer cells, B lymphocytes, and dendritic cells. Blood 88:474a, 1996 (abstr, suppl 1)
249. Hunte BE, Hudak S, Campbell D, Xu Y, Rennick D: flk2/flt3 ligand is a potent cofactor for the growth of primitive B cell progenitors. J Immunol 156:489, 1996
250. Peschon JJ, Morrissey PJ, Grabstein KH, Ramsdell FJ, Maraskovsky E, Gliniak BC, Park LS, Ziegler SF, Williams DE, Ware CB, Meyer JD, Davison BL: Early lymphocyte expansion is severely impaired in interleukin 7 receptor-deficient mice. J Exp Med 180:1955, 1994
251. Ray RJ, Paige CJ, Furlonger C, Lyman SD, Rottapel R: Flt3 ligand supports the differentiation of early B cell progenitors in the presence of interleukin-11 and interleukin-7. Eur J Immunol 26:1504, 1996
252. Veiby OP, Lyman SD, Jacobsen SEW: Combined signaling through interleukin-7 receptors and flt3 but not c-kit potently and selectively promotes B-cell commitment and differentiation from uncommitted murine bone marrow progenitor cells. Blood 88:1256, 1996
253. Saeland S, Moreau I, Duvert V, Pandrau D, Bancherau J: In vitro growth and maturation of human B-cell precursors. Curr Top Microbiol Immunol 182:85, 1992
254. Abboud MR, Xu F, Payne A, Laver J: Effects of recombinant human Steel factor (c-kit ligand) on early cord blood hematopoietic precursors. Exp Hematol 22:388, 1994
255. Rawlings DJ, Quan SG, Kato RM, Witte ON: Long-term culture system for selective growth of human B-cell progenitors. Proc Natl Acad Sci USA 92:1570, 1995
256. Namikawa R, Muench MO, de Vries JE, Roncarolo MG: The FLK2/FLT3 ligand synergizes with interleukin-7 in promoting stromal-cell-independent expansion and differentiation of human fetal pro-B cells in vitro. Blood 87:1881, 1996
257. Mekori T, Phillips RA: The immune response in mice of genotypes W-Wv and Sl-Sld1. Proc Soc Exp Biol Med 132:115, 1969
258. Asamoto H, Mandel TE: Thymus mice bearing the steel mutation. Morphologic studies on fetal, neonatal, organ-cultured, and grafted fetal thymus. Lab Invest 45:418, 1981
259. de Vries P, Brasel KA, McKenna HJ, Williams DE, Watson JD: Thymus reconstitution by c-kit-expressing hematopoietic stem cells purified from adult mouse bone marrow. J Exp Med 176:1503, 1992
260. Matsuzaki Y, Gyotoku J, Ogawa M, Nishikawa S, Katsura Y, Gachelin G, Nakauchi H: Characterization of c-kit positive intrathymic stem cells that are restricted to lymphoid differentiation. J Exp Med 178:1283, 1993
261. - thymocytes: Synergy with IL-7. Cell Immunol 157:118, 1994
262. Moore TA, Zlotnik A: Differential effects of Flk-2/Flt-3 ligand and stem cell factor on murine thymic progenitor cells. J Immunol 158:4187, 1997
263. Tjonnfjord GE, Veiby OP, Steen R, Egeland T: T lymphocyte differentiation in vitro from adult human prethymic CD34+ bone marrow cells. J Exp Med 177:1531, 1993
264. Freedman AR, Zhu H, Levine JD, Kalams S, Scadden DT: Generation of human T lymphocytes from bone marrow CD34+ cells in vitro. Nat Med 2:46, 1996
265. Suva MR, Hoffman R, Srour EF, Ascensao JL: Generation of human natural killer cells from immature progenitors does not require marrow stromal cells. Blood 84:841, 1994
266. + hematopoietic progenitor cells. Blood 85:3538, 1995
267. + hematopoietic progenitor cells. Blood 87:2632, 1996
268. + hematopoetic progenitor cells (HPCs) when combined with interleukin 15 (IL-15). Blood 88:105b, 1996(abstr. suppl 1)
269. Peters JH, Gieseler R, Thiele B, Steinbach F: Dendritic cells: From ontogenetic orphans to myelomonocytic descendants. Immunol Today 17:273, 1996
270. Caux C, Liu YJ, Banchereau J: Recent advances in the study of dendritic cells and follicular dendritic cells. Immunol Today 16:2, 1995
271. + blood progenitors for anticancer therapy. Exp Hematol 23:1463, 1995
272. Saunders D, Lucas K, Ismaili J, Wu J, Maraskovsky E, Dunn A, Shortman K: Dendritic cell development in culture from thymic precursor cells in the absence of granulocyte/macrophage colony-stimulating factor. J Exp Med 184:2185, 1996
273. Maraskovsky E, Brasel K, Teepe M, Roux ER, Lyman SD, Shortman K, McKenna HJ: Dramatic increase in the numbers of functionally mature dendritic cells in Flt3 ligand-treated mice: Multiple dendritic cell subpopulations identified. J Exp Med 184:1953, 1996
274. Sanchez MJ, Holmes A, Miles C, Dzierzak E: Characterization of the first definitive hematopoietic stem cells in the AGM and liver of the mouse embryo. Immunity 5:513, 1996
275. Wineman JP, Nishikawa S, Muller-Sieburg CE: Maintenance of high levels of pluripotent hematopoietic stem cells in vitro: Effect of stromal cells and c-kit. Blood 81:365, 1993
276. de Jong MO, Rozemuller H, Kieboom D, Visser JW, Wognum AW, Wagemaker G: Purification of Depopulating hemopoietic cells based on binding of biotinylated Kit ligand. Leukemia 10:1813, 1996
277. Osawa M, Hamada K-I, Hamada H, Nakauchi H: Long-term lympho-hematopoietic reconstitution by a single CD34-low/negative hematopoietic stem cell. Science 273:242, 1996
278. Keller JR, Ortiz M, Spence SE, Lohrey N, Ruscetti FW: Characterization of a c-kit negative primitive murine hematopoietic stem cell. Exp Hematol 23:815a, 1995
279. Jones RJ, Collector MI, Barber JP, Vala MS, Fackler MJ, May WS, Griffin CA, Hawkins AL, Zehnbauer BA, Hilton J, Colvin OM, Sharkis SJ: Characterization of mouse lymphohematopoietic stem cells lacking spleen colony-forming activity. Blood 88:487, 1996
280. Katayama N, Shih JP, Nishikawa S, Kina T, Clark SC, Ogawa M: Stage-specific expression of c-kit protein by murine hematopoietic progenitors. Blood 82:2353, 1993
281. Visser JW, Rozemuller H, de Jong MO, Belyavsky A: The expression of cytokine receptors by purified hemopoietic stem cells. Stem Cells 11:49, 1993
282. de Vries P, Brasel KA, Eisenman JR, Alpert AR, Williams DE: The effect of recombinant mast cell growth factor on purified murine hematopoietic stem cells. J Exp Med 173:1205, 1991
283. Tsuji K, Zsebo KM, Ogawa M: Enhancement of murine blast cell colony formation in culture by recombinant rat stem cell factor, ligand for c-kit. Blood 78:1223, 1991
284. Migliaccio G, Migliaccio AR, Valinsky J, Langley KE, Zsebo KM, Visser JMW, Adamson JW: Stem cell factor induces proliferation and differentiation of highly enriched murine hemopoietic cells. Proc Natl Acad Sci USA 88:7420, 1991
285. - murine hematopoietic progenitors. Exp Hematol 19:994, 1991
286. Williams N, Bertoncello I, Kavnoudias H, Zsebo K, McNiece I: Recombinant rat stem cell factor stimulates the amplification and differentiation of fractionated mouse stem cell populations. Blood 79:58, 1992
287. Tsuji K, Lyman SD, Sudo T, Clark SC, Ogawa M: Enhancement of murine hematopoiesis by synergistic interactions between Steel factor (ligand for c-kit), interleukin-11, and other early acting factors in culture. Blood 79:2855, 1992
288. Lowry PA, Deacon D, Whitefield P, McGrath HE, Quesenberry PJ: Stem cell factor induction of in vitro murine hematopoietic colony formation by "subliminal" cytokine combinations: the role of "anchor factors." Blood 80:663, 1992
289. Muench MO, Schneider JG, Moore MA: Interactions among colony-stimulating factors, IL-1 beta, IL-6, and kit-ligand in the regulation of primitive murine hematopoietic cells. Exp Hematol 20:339, 1992
290. Jacobsen SEW, Veiby OP, Smeland EB: Cytotoxic lymphocyte maturation factor (interleukin 12) is a synergistic growth factor for hematopoietic stem cells. J Exp Med 178:413, 1993
291. Keller JR, Gooya JM, Ruscetti FW: Direct synergistic effects of leukemia inhibitory factor on hematopoietic progenitor cell growth: Comparison with other hematopoietins that use the gp130 receptor subunit. Blood 88:863, 1996
292. Broxmeyer HE, Lu L, Cooper S, Ruggieri L, Li ZH, Lyman SD: Flt3 ligand stimulates/costimulates the growth of myeloid stem/ progenitor cells. Exp Hematol 23:1121, 1995
293. Fujimoto K, Lyman SD, Hirayama F, Ogawa M: Isolation and characterization of primitive hematpoietic progenitors of murine fetal liver. Exp Hematol 24:285, 1996
294. Jacobsen FW, Stokke T, Jacobsen SEW: Transforming growth factor-beta potently inhibits the viability-promoting activity of stem cell factor and other cytokines and induces apoptosis of primitive murine hematopoietic progenitor cells. Blood 86:2957, 1995
295. Jacobsen FW, Dubois CM, Rusten LS, Veiby OP, Jacobsen SEW: Inhibition of stem cell factor-induced proliferation of primitive murine hematopoietic progenitor cells signaled through the 75-kilodalton tumor necrosis factor receptor. Regulation of c-kit and p53 expression. J Immunol 154:3732, 1995
296. Yonemura Y, Ku H, Lyman SD, Ogawa M: In vitro expansion of hematopoietic progenitors and maintenance of stem cells: Comparison between FLT3/FLK-2 ligand and KJT ligand. Blood 89:1915, 1997
297. + cells. Blood 78:161a, 1991 (abstr, suppl 1)
298. Civin C, Almaida-Porada G, Lee M, Olweus J, Terstappen L, Zanjani E: Sustained, retransplantable, multilineage engraftment of highly purified adult human bone marrow stem cells in vivo. Blood 88:4102, 1996
299. Larochelle A, Vormoor J, Hanenberg H, Wang J, Bhatia M, Lapidot T, Moritz T, Murdoch B, Xiao X, Kato I, Williams D, Dick J: Identification of primitive human hematopoietic cells capable of repopulating NOD/SCID mouse bone marrow: Implications for gene therapy. Nat Med 2:1329, 1996
300. Berardi AC, Wang A, Levine JD, Lopez P, Scadden DT: Functional isolation and characterization of human hematopoietic stem cells. Science 267:104, 1995
301. high cells. Blood 82:3283, 1993
302. + human marrow cells that express low levels of Kit protein are enriched for long-term marrow-engrafting cells. Blood 87:4136, 1996
303. Laver JH, Abboud MR, Kawashima I, Leary AG, Ashman LK, Ogawa M: Characterization of c-kit expression by primitive hematopoietic progenitors in umbilical cord blood. Exp Hematol 23:1515, 1995
304. - cells cultured with interleukin-3, granulocyte colony-stimulating factor, or granulocyte-macrophage colony-stimulating factor. Exp Hematol 77:2316, 1991
305. Carow CE, Hangoc G, Cooper SH, Williams DE, Broxmeyer HE: Mast cell growth factor (c-kit ligand) supports the growth of human multipotential progenitor cells with a high replating potential. Blood 78:2216, 1991
306. Brandt J, Briddell RA, Srour EF, Leemhuis TB, Hoffman R: Role of c-kit ligand in the expansion of human hematopoietic progenitor cells. Blood 79:634, 1992
307. + cord blood cells in the presence of recombinant human stem cell factor. Blood 79:2620, 1992
308. - cells and synergizes with stem cell factor, interleukin-3, and granulocyte-macrophage colony-stimulating factor. Exp Hematol 21:1668, 1993
309. + highly purified blood progenitors expressing HLA-DR or different levels of c-kit protein. Blood 84:4099, 1994
310. Muench MO, Roncarolo MG, Menon S, Xu Y, Kastelein R, Zurawski S, Hannum CH, Culpepper J, Lee F, Namikawa R: FLK-2/ FLT-3 ligand regulates the growth of early myeloid progenitors isolated from human fetal liver. Blood 85:963, 1995
311. Brashem-Stein C, Flowers DA, Bernstein ID: Regulation of colony forming cell generation by flt-3 ligand. Br J Haematol 94:17, 1996
312. - cells and maintains progenitor cells in vitro. Blood 87:3563, 1996
313. -) human hematopoietic cells: Novel responses to Flt3-ligand and thrombopoietin. J Exp Med 183:2551, 1996
314. Elwood NJ, Zogos H, Willson T, Begley CG: Retroviral transduction of human progenitor cells: Use of granulocyte colony-stimulating factor plus stem cell factor to mobilize progenitor cells in vivo and stimulation by Flt3/Flk-2 ligand in vitro. Blood 88:4452, 1996
315. + progenitors to sustain long-term hematopoiesis in immune-deficient mice after ex vivo retroviral-mediated transduction. Blood 89:446, 1997
316. Eaves CJ, Cashman JD, Eaves AC: Methodology of long-term culture of human hemopoietic cells. J Tiss Cult Methods 13:55, 1991
317. Gartner S, Kaplan HS: Long-term culture of human bone marrow cells. Proc Natl Acad Sci USA 77:4756, 1980
318. Miller CL, Rebel VI, Lemieux ME, Helgason CD, Lansdorp PM, Eaves CJ: Studies of W mutant mice provide evidence for alternate mechanisms capable of activating hematopoietic stem cells. Exp Hematol 24:185, 1996
319. Kodama H, Nose M, Yamaguchi Y, Tsunoda J, Suda T, Nishikawa S, Nishikawa S: In vitro proliferation of primitive hemopoietic stem cells supported by stromal cells: Evidence for the presence of a mechanism(s) other than that involving c-kit receptor and its ligand. J Exp Med 176:351, 1992
320. Liesveld JL, Broudy VC, Harbol AW, Abboud CN: Effect of stem cell factor on myelopoiesis potential in human Dexter-type culture systems. Exp Hematol 23:202, 1995
321. Sutherland HJ, Hogge DE, Cook D, Eaves CJ: Alternative mechanisms with and without steel factor support primitive human hematopoiesis. Blood 81:1465, 1993
322. Heinrich MC, Dooley DC, Freed AC, Band L, Hoatlin ME, Keeble WW, Peters ST, Silvey KV, Ey FS, Kabat D, Maziarz RT, Bagby GC Jr: Constitutive expression of steel factor gene by human stromal cells. Blood 82:771, 1993
323. Papayannopoulou T, Craddock C, Nakamoto B, Priestley GV, Wolf NS: The VLA4/VCAM-1 adhesion pathway defines contrasting mechanisms of lodgement of transplanted murine hemopoietic progenitors between bone marrow and spleen. Proc Natl Acad Sci USA 92:9647, 1995
324. Miyake K, Weissman IL, Gieenberger JS, Kincade PW: Evidence for a role of the integrin VLA-4 in lympho-hemopoiesis. J Exp Med 173:599, 1991
325. Williams DA, Rios M, Stephens C, Patel VP: Fibronectin and VLA-4 in haematopoietic stem cell-microenvironment interactions. Nature 352:438, 1991
326. Hirsch E, Iglesias A, Potocnik AJ, Hartmann U, Fassler R: Impaired migration but not differentiation of haematopoietic stem cells in the absence of beta 1 integrins. Nature 380:171, 1996
327. Arroyo AG, Yang JT, Rayburn H, Hynes RO: Differential requirements for alpha4 integrins during fetal and adult hematopoiesis. Cell 85:997, 1996
328. Levesque JP, Leavesley DI, Niutta S, Vadas M, Simmons PJ: Cytokines increase human hemopoietic cell adhesiveness by activation of very late antigen (VLA)-4 and VLA-5 integrins. J Exp Med 181:1805, 1995
329. Kovach NL, Lin N, Yednock T, Harlan JM, Broudy VC: Stem cell factor modulates avidity of α4β1 and α5β1 integrins expressed on hematopoietic cell lines. Blood 85:159, 1995
330. Kinashi T, Springer TA: Steel factor and c-kit regulate cell-matrix adhesion. Blood 83:1033, 1994
331. Dastych J, Metcalfe DD: Stem cell factor induces mast cell adhesion to fibronectin. J Immunol 152:213, 1994
332. Hanenberg H, Xiao XL, Dilloo D, Hashino K, Kato I, Williams DA: Colocalization of retrovirus and target cells on specific fibronectin fragments increases genetic transduction of mammalian cells. Nat Med 2:876, 1996
333. Hurley RW, McCarthy JB, Verfaillie CM: Direct adhesion to bone marrow stroma via fibronectin receptors inhibits hematopoietic progenitor cell proliferation. J Clin Invest 96:511, 1995
334. Moritz T, Patel VP, Williams DA: Bone marrow extracellular matrix molecules improve gene transfer into human hematopoietic cells via retroviral vectors. J Clin Invest 93:1451, 1994
335. Kodama H, Nose M, Niida S, Nishikawa S, Nishikawa S: Involvement of the c-kit receptor in the adhesion of hematopoietic stem cells to stromal cells. Exp Hematol 22:979, 1994
336. Long MW, Briddell R, Walter AW, Bruno E, Huffman R: Human hematopoietic stem cell adherence to cytokines and matrix molecules. J Clin Invest 90:251, 1992
337. Kaneko Y, Takenawa J, Yoshida O, Fujita K, Sugimoto K, Nakayama H, Fujita J: Adhesion of mouse mast cells to fibroblasts: adverse effects of Steel (SI) mutation. J Cell Physiol 147:224, 1991
338. Avraham H, Scadden DT, Chi S, Broudy VC, Zsebo KM, Groopman JE: Interaction of human bone marrow fibroblasts with megakaryocytes: Role of the c-kit ligand. Blood 80:1679, 1992
339. Adachi S, Ebi Y, Nishikawa S, Hayashi S, Yamazaki M, Kasugai T, Yamamura T, Nomura S, Kitamura Y: Necessity of extracellular domain of W (c-kit) receptors for attachment of murine cultured mast cells to fibroblasts. Blood 79:650, 1992
340. Broudy VC, Lin NL, Priestley GV, Nocka K, Wolf NS: Interaction of stem cell factor and its receptor c-kit mediates lodgment and acute expansion of hematopoietic cells in the murine spleen. Blood 88:75, 1996
341. Okumura N, Tsuji K, Ebihara Y, Tanaka I, Sawai N, Koike K, Komiyama A, Nakahata T: Chemotactic and chemokinetic activities of stem cell factor on murine hematopoietic progenitor cells. Blood 87:4100, 1996
342. Nilsson G, Butterfield JH, Nilsson K, Siegbahn A: Stem cell factor is a chemotactic for human mast cells. J Immunol 153:3717, 1994
343. Meininger CJ, Yano H, Rottapel R, Bernstein A, Zsebo KM, Zetter BR: The c-kit receptor ligand functions as a mast cell chemoat-tractant. Blood 79:958, 1992
344. d mice as a single factor. Blood 79:913, 1992
345. Katayama N, Clark SC, Ogawa M: Growth factor requirement for survival in cell-cycle dormancy of primitive murine lymphohematopoietic progenitors. Blood 81:610, 1993
346. Li CL, Johnson GR: Stem cell factor enhances the survival but not the self-renewal of murine hematopoietic long-term repopulating cells. Blood 84:408, 1994
347. Keller JR, Ortiz M, Ruscetti FW: Steel factor (c-kit ligand) promotes the survival of hematopoietic stem/progenitor cells in the absence of cell division. Blood 86:1757, 1995
348. Brandt JE, Bhalla K, Hoffman R: Effects of interleukin-3 and c-kit ligand on the survival of various classes of human hematopoietic progenitor cells. Blood 83:1507, 1994
349. Hong DS, Huss R, Beckham C, Hoy CA, Storb R, Deeg HJ: Major histocompatibility complex class II-mediated inhibition of hemopoiesis in vitro and in vivo is abrogated by c-kit ligand. Transplant Proc 27:642, 1995
350. Veiby OP, Jacobsen FW, Cui L, Lyman SD, Jacobsen SEW: The flt3 ligand promotes the survival of primitive hemopoietic progenitor cells with myeloid as well as B lymphoid potential. Suppression of apoptosis and counteraction by TNF-alpha and TGF-beta. J Immunol 157:2953, 1996
351. +++ human umbilical cord blood myeloid progenitors in serum-depleted culture medium. Ann Hematol 72:131, 1996
352. Keller JR, Jacobsen SEW, Dubois CM, Hestdal K, Ruscetti FW: Transforming growth factor-beta: A bidirectional regulator of hematopoietic cell growth. Int J Cell Cloning 10:2, 1992
353. McNiece IK, Bertoncello I, Keller JR, Ruscetti FW, Hartley CA, Zsebo KM: Transforming growth factor beta inhibits the action of stem cell factor on mouse and human hematopoietic progenitors. Int J Cell Cloning 10:80, 1992
354. Ohishi K, Katayama N, Itoh R, Mahmud N, Miwa H, Kita K, Minami N, Shirakawa S, Lyman SD, Shiku H: Accelerated cell-cycling of hematopoietic progenitors by the flt3 ligand that is modulated by transforming growth factor-β. Blood 87:1718, 1996
355. Jacobsen SEW, Veiby OP, Myklebust J, Okkenhaug C, Lyman SD: Ability of flt3 ligand to stimulate the in vitro growth of primitive muirine hematopoietic progenitors is potently and directly inhibited by transforming growth factor-β and tumor necrosis factor-α. Blood 87:5016, 1996
356. Jacobsen SEW, Jacobsen FW, Fahlman C, Rusten LS: TNF-alpha, the great imitator: Role of p55 and p75 TNF receptors in hematopoiesis. Stem Cells 12:111, 1994
357. Jacobsen FW, Veiby OP, Stokke T, Jacobsen SEW: TNF-alpha bidirectionally modulates the viability of primitive murine hematopoietic progenitor cells in vitro. J Immunol 157:1193, 1996
358. Jacobsen SEW, Veiby OP, Myklebust J, Okkenhaug C, Lyman SD: Ability of flt3 ligand to stimulate the in vitro growth of primitive murine hematopoietic progenitors is potently and directly inhibited by transforming growth factor-β and tumor necrosis factor-α. Blood 87:5016, 1996
359. Rusten LS, Smeland EB, Jacobsen FW, Lien E, Lesslauer W, Loetscher H, Dubois CM, Jacobsen SEW: Tumor necrosis factor-alpha inhibits stem cell factor-induced proliferation of human bone marrow progenitor cells in vitro. Role of p55 and p75 tumor necrosis factor receptors. J Clin Invest 94:165, 1994
360. Kurosawa K, Miyazawa K, Gotoh A, Katagiri T, Nishimaki J, Ashman LK, Toyama K: Immobilized anti-KIT monoclonal antibody induces ligand-independent dimerization and activation of Steel factor receptor: Biologic similarity with membrane-bound form of Steel factor rather than its soluble form. Blood 87:2235, 1996
361. Miyazawa K, Williams DA, Gotoh A, Nishimaki J, Broxmeyer HE, Toyama K: Membrane-bound Steel factor induces more persistent tyrosine kinase activation and longer life span of c-kit gene-encoded protein than its soluble form. Blood 85:641, 1995
362. Gurney AL, Carver-Moore K, de Sauvage FJ, Moore MW: Thrombocytopenia in c-mpl-deficient mice. Science 265:1445, 1994
363. Carver-Moore K, Broxmeyer HE, Luoh S-M, Cooper S, Peng J, Burstein SA, Moore MW, de Sauvage FJ: Low levels of erythroid and myeloid progenitors in thrombopoietin-and c-mpl-deficient mice. Blood 88:803, 1996
364. Miller CL, Rebel VI, Helgason CD, Lansdorp PM, Eaves CJ: Impaired Steel factor responsiveness differentially affects the detection and long-term maintenance of fetal liver hematopoietic stem cells in vivo. Blood 89:1214, 1997
365. Van XQ, Briddell R, Hartley C, Stoney G, Samal B, McNiece I: Mobilization of long-term hematopoietic reconstituting cells in mice by the combination of stem cell factor plus granulocyte colony-stimulating factor. Blood 84:795, 1994
366. Neta R, Williams D, Selzer F, Abrams J: Inhibition of c-kit ligand/Steel factor by antibodies reduces survival of lethally irradiated mice. Blood 81:324, 1993
367. Zsebo KM, Smith KA, Hartley CA, Greenblatt M, Cooke K, Rich W, McNiece IK: Radioprotection of mice by recombinant rat stem cell factor. Proc Natl Acad Sci USA 89:9464, 1992
368. Patchen ML, Fischer R, Schmauder-Chock EA, Williams DE: Mast cell growth factor enhances multilineage hematopoietic recovery in vivo following radiation-induced aplasia. Exp Hematol 22:31, 1994
369. Schuening FG, Appelbaum FR, Deeg HJ, Sullivan-Pepe M, Graham TC, Hackman R, Zsebo KM, Storb R: Effects of recombinant canine stem cell factor, a c-kit ligand, and recombinant granulocyte colony-stimulating factor on hematopoietic recovery after otherwise lethal total body irradiation. Blood 81:20, 1993
370. Molineux G, Migdalska A, Szmitkowski M, Zsebo K, Dexter TM: The effects on hematopoiesis of recombinant stem cell factor (ligand for c-kit) administered in vivo to mice either alone or in combination with granulocyte colony-stimulating factor. Blood 78:961, 1991
371. Fleming WH, Alpern EJ, Uchida N, Ikuta K, Weissman IL: Steel factor influences the distribution and activity of murine hematopoietic stem cells in vivo. Proc Natl Acad Sci USA 90:3760, 1993
372. Briddell RA, Hartley CA, Smith KA, McNiece IK: Recombinant rat stem cell factor synergizes with recombinant human granulocyte colony-stimulating factor in vivo in mice to mobilize peripheral blood progenitor cells that have enhanced repopulating potential. Blood 82:1720, 1993
373. Yan XQ, Hartley C, McElroy P, Chang A, McCrea C, McNiece I: Peripheral blood progenitor cells mobilized by recombinant human granulocyte colony-stimulating factor plus recombinant rat stem cell factor contain long-term engrafting cells capable of cellular proliferation for more than two years as shown by serial transplantation in mice. Blood 85:2303, 1995
374. Bodine DM, Seidel NE, Zsebo KM, Orlic D: In vivo administration of stem cell factor to mice increases the absolute number of pluripotent hematopoietic stem cells. Blood 82:445, 1993
375. de Revel T, Appelbaum FR, Storb R, Schuening F, Nash R, Deeg J, McNiece I, Andrews R, Graham T: Effects of granulocyte colony-stimulating factor and stem cell factor, alone and in combination, on the mobilization of peripheral blood cells that engraft lethally irradiated dogs. Blood 83:3795, 1994
376. Andrews RG, Briddell RA, Knitter GH, Rowley SD, Appelbaum FR, McNiece IK: Rapid engraftment by peripheral blood progenitor cells mobilized by recombinant human stem cell factor and recombinant human granulocyte colony-stimulating factor in nonhuman primates. Blood 85:15, 1995
377. Andrews RG, Briddell RA, Knitter GH, Opie T, Bronsden M, Myerson D, Appelbaum FR, McNiece IK: In vivo synergy between recombinant human stem cell factor and recombinant human granulocyte colony-stimulating factor in baboons: Enhanced circulation of progenitor cells. Blood 84:800, 1994
378. Andrews RG, Bensinger WI, Knitter GH, Bartelmez SH, Longin K, Bernstein ID, Appelbaum FR, Zsebo KM: The ligand for c-kit, stem cell factor, stimulates the circulation of cells that engraft lethally irradiated baboons. Blood 80:2715, 1992
379. Tong J, Gordon MS, Srour EF, Cooper RJ, Orazi A, McNiece I, Hoffman R: In vivo administration of recombinant methionyl human stem cell factor expands the number of human marrow hematopoietic stem cells. Blood 82:784, 1993
380. McNiece IK, Briddell RA, Yan XQ, Hartley CA, Gringeri A, Foote MA, Andrews RG: The role of stem cell factor in mobilization of peripheral blood progenitor cells. Leuk Lymphoma 15:405, 1994
381. Bodine DM, Seidel NE, Orlic D: Bone marrow collected 14 days after in vivo administration of granulocyte colony-stimulating factor and stem cell factor to mice has 10-fold more repopulating ability than untreated bone marrow. Blood 88:89, 1996
382. Dunbar CE, Seidel NE, Doren S, Sellers S, Cline AP, Metzger ME, Agricola BA, Donahue RE, Bodine DM: Improved retroviral gene transfer into murine and Rhesus peripheral blood or bone marrow repopulating cells primed in vivo with stem cell factor and granulocyte colony-stimulating factor. Proc Natl Acad Sci USA 93:11871, 1996
383. Brasel K, McKenna HJ, Morrissey PJ, Charrier K, Morris AE, Lee CC, Williams DE, Lyman SD: Hematologie effects of flt3 ligand in vivo in mice. Blood 88:2004, 1996
384. Brasel K, McKenna HJ, Charrier K, Morrissey P, Williams DE, Lyman SD: Flt3 ligand synergizes with granulocyte-macrophage colony-stimulating factor or granulocyte colony-stimulating factor to mobilize hematopoietic progenitor cells into the peripheral blood of mice. Blood 90:3781, 1997
385. + cell mobilization to blood in rhesus monkeys. Blood 88:642a, 1996 (abstr, suppl 1)
386. Langley KE, Bennett LG, Wypych J, Yancik SA, Liu X-D, Westcott KR, Chang DG, Smith KA, Zsebo KM: Soluble stem cell factor in human serum. Blood 81:656, 1993
387. Abkowitz JL, Hume H, Yancik SA, Bennett LG, Matsumoto AM: Stem cell factor serum levels may not be clinically relevant. Blood 87:4017, 1996
388. Lyman SD, Seaberg M, Hanna R, Zappone J, Brasel K, Abkowitz JL, Prchal JT, Schultz JC, Shahidi NT: Plasma/serum levels of flt3 ligand are low in normal individuals and highly elevated in patients with Fanconi anemia and acquired aplastic anemia. Blood 86:4091, 1995
389. Wodnar-Filipowicz A, Lyman SD, Gratwohl A, Tichelli A, Speck B, Nissen C: Flt3 ligand level reflects hematopoietic progenitor cell function in multilineage bone marrow failure. Blood 88:4493, 1996
390. Zwierzina H, Torok-Storb B, Rollinger-Holzinger I, Anderson JE, Nuessler V, Lyman SD: Serum levels of flt3 ligand are associated with disease stage in patients with myelodysplastic syndrome. Blood 88:99a, 1996 (abstr, suppl 1)
391. Lebsack ME, Hoek JA, Maraskovsky E, McKenna HJ: FLT3 ligand induces stem and dendritic cell mobilization in healthy volunteers. International Society for Hematotherapy and Graft Engineering Meeting. Bordeaux, France, May 31-June 3, 1997
392. Winton EF, Bucur SZ, Bray RA, Toba K, Williams DE, McClure HM, Lyman SD: The hematopoietic effects of recombinant human (rh) Flt3 ligand administered to non-human primates. Blood 86:424a, 1995 (abstr, suppl 1)
393. Bodine DM, Seidel NE, Gale MS, Nienhuis AW, Orlic D: Efficient retrovirus transduction of mouse pluripotent hematopoietic stem cells mobilized into the peripheral blood by treatment with granulocyte colony-stimulating factor and stem cell factor. Blood 84:1482, 1994
394. Kohn DB, Weinberg KI, Nolta JA, Heiss LN, Lenarsky C, Crooks GM, Hanley ME, Annett G, Brooks JS, el-Khoureiy A, Lawrence K, Wells S, Moen RC, Bastian J, Williams-Herman DE, Elder M, Wara D, Bowen T, Hershfield MS, Mullen CA, Blaese RM, Parkman R: Engraftment of gene-modified umbilical cord blood cells in neonates with adenosine deaminase deficiency. Nat Med 1:1017, 1995
395. Dick JE, Kamel-Reid S, Murdoch B, Doedens M: Gene transfer into normal human hematopoietic cells using in vitro and in vivo assays. Blood 78:624, 1991
396. Nolta JA, Dao MA, Wells S, Smogorzewska EM, Kohn DB: Transduction of pluripotent human hematopoietic stem cells demonstrated by clonal analysis after engraftment in immune-deficient mice. Proc Natl Acad Sci USA 93:2414, 1996
397. Williams DA: Ex vivo expansion of hematopoietic stem and progenitor cells-Robbing Peter to pay Paul? Blood 81:3169, 1993
398. Lange W, Henschler R, Mertelsmann R: Biological and clinical advances in stem cell expansion. Leukemia 10:943, 1996
399. Emerson SG: Ex vivo expansion of hematopoietic precursors, progenitors, and stem cells: The next generation of cellular therapeutics. Blood 87:3082, 1996
400. Rill DR, Santana VM, Roberts WM, Nilson T, Bowman LC, Krance RA, Heslop HE, Moen RC, Me JN, Brenner MK: Direct demonstration that autologous bone marrow transplantation for solid tumors can return a multiplicity of tumorigenic cells. Blood 84:380, 1994
401. + cells present in autologous transplants of chronic myelogenous leukemia (CML) contribute to relapse after autologous bone marrow in CML. Blood 83:3068, 1994
402. Muench MO, Firpo MT, Moore MA: Bone marrow transplantation with interleukin-1 plus kit-ligand ex vivo expanded bone marrow accelerates hematopoietic reconstitution in mice without the loss of stem cell lineage and proliferative potential. Blood 81:3463, 1993
403. Yonemura Y, Ku H, Lyman SD, Ogawa M: In vitro expansion of hematopoietic progenitors and maintenance of stem cells: Comparison between flt3/flk-2 ligand and kit ligand. Blood 89:1915, 1997
404. + cells in serum-free cultures containing steel factor, interleukin-6, and erythropoietin with maintenance of cells with long-term in vivo reconstituting potential. Blood 83:128, 1994
405. Holyoake TL, Freshney MG, McNair L, Parker AN, McKay PJ, Steward WP, Fitzsimons E, Graham GJ, Pragnell IB: Ex vivo expansion with stem cell factor and interleukin-11 augments both short-term recovery posttransplant and the ability to serially transplant marrow. Blood 87:4589, 1996
406. Yonemura Y, Ku H, Hirayama F, Souza LM, Ogawa M: Interleukin 3 or interleukin 1 abrogates the reconstituting ability of hematopoietic stem cells. Proc Natl Acad Sci USA 93:4040, 1996
407. + cells into the myeloid lineage. Blood 80:1405, 1992
408. Henschler R, Brugger W, Luft T, Frey T, Mertelsmann R, Kanz L: Maintenance of transplantation potential in ex vivo expanded CD34(+)-selected human peripheral blood progenitor cells. Blood 84:2898, 1994
409. Srour EF, Brandt JE, Briddell RA, Grigsby S, Leemhuis T, Hoffman R: Long-term generation and expansion of human primitive hematopoietic progenitor cells in vitro. Blood 81:661, 1993
410. Petzer AL, Hogge DE, Landsdorp PM, Reid DS, Eaves CJ: Self-renewal of primitive human hematopoietic cells (long-term-culture-initiating cells) in vitro and their expansion in defined medium. Proc Natl Acad Sci USA 93:1470, 1996
411. Karlsson S: Treatment of genetic defects in hematopoietic cell function by gene transfer. Blood 78:2481, 1991
412. Brenner MK, Rill DR, Holladay MS, Heslop HE, Moen RC, Buschle M, Krance RA, Santana VM, Anderson WF, Ihle JN: Gene marking to determine whether autologous marrow infusion restores long-term haemopoiesis in cancer patients. Lancet 342:1134, 1993
413. Koller MR, Oxender M, Brott DA, Palsson BØ: flt-3 ligand is more potent than c-kit ligand for the synergistic stimulation of ex vivo hematopoietic cell expansion. J Hematother 5:449, 1996
414. Miller AD: Human gene therapy comes of age. Nature 357:455, 1992
415. Kohn DB: The current status of gene therapy using hematopoietic stem cells. Curr Opin Pediatr 7:56, 1995
416. Williams DA, Lemischka IR, Nathan DG, Mulligan RC: Introduction of new genetic material into pluripotent haematopoietic stem cells of the mouse. Nature 310:476, 1984
417. Bodine DM, Karlsson S, Nienhuis AW: Combination of interleukins 3 and 6 preserves stem cell function in culture and enhances retrovirus-mediated gene transfer into hematopoietic stem cells. Proc Natl Acad Sci USA 86:8897, 1989
418. Luskey BD, Rosenblatt M, Zsebo K, Williams DA: Stem cell factor, interleukin-3, and interleukin-6 promote retroviral-mediated gene transfer into murine hematopoietic stem cells. Blood 80:396, 1992
419. Fraser CC, Eaves CJ, Szilvassy SJ, Humphries RK: Expansion in vitro of retrovirally marked totipotent hematopoietic stem cells. Blood 76:1071, 1990
420. Correll PH, Colilla S, Dave HP, Karlsson S: High levels of human glucocerebrosidase activity in macrophages of long-term reconstituted mice after retroviral infection of hematopoietic stem cells. Blood 80:331, 1992
421. Cairo MS, Law P, van de Ven C, Plunkett JM, Williams D, Ishizawa L, Gee A: The in vitro effects of stem cell factor and PIXY321 on myeloid progenitor formation (CFU-GM) from immunomagnetic separated CD34+ cord blood. Pediatr Res 32:277, 1992
422. Cassel A, Cottler-Fox M, Doren S, Dunbar CE: Retroviral-mediated gene transfer into CD34-enriched human peripheral blood stem cells. Exp Hematol 21:585, 1993
423. Dunbar CE, Cottler-Fox M, O' Shaughnessy JA, Doren S, Carter C, Berenson R, Brown S, Moen RC, Greenblatt J, Stewart FM, Leitman SF, Wilson WH, Cowan K, Young NS, Nienhuis AW: Retrovirally marked CD34-enriched peripheral blood and bone marrow cells contribute to long-term engraftment after autologous transplantation. Blood 85:3048, 1995
424. Nolta JA, Crooks GM, Overell RW, Williams DE, Kohn DB: Retroviral vector-mediated gene transfer into primitive human hematopoietic progenitor cells: Effects of mast cell growth factor (MGF) combined with other cytokines. Exp Hematol 20:1065, 1992
425. Nolta JA, Smogorzewska EM, Kohn DB: Analysis of optimal conditions for retroviral-mediated transduction of primitive human hematopoietic cells. Blood 86:101, 1995
426. Schwarzenberger P, Spence SE, Gooya JM, Michiel D, Curiel DT, Ruscetti FW, Keller JR: Targeted gene transfer to human hematopoietic progenitor cell lines through the c-kit receptor. Blood 87:472, 1996
427. Mayordomo JI, Zorina T, Storkus WJ, Zitvogel L, Celluzzi C, Falo LD, Melief CJ, Ildstad ST, Kast WM, Deleo AB, Lotze MT: Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity. Nat Med 1:1297, 1995
428. Thomson AW, Lu L, Murase N, Demetris AJ, Rao AS, Starzl TE: Microchimerism, dendritic cell progenitors and transplantation tolerance. Stem Cells 13:622, 1995
429. Young JW, Inaba K: Dendritic cells as adjuvants for class I major histocompatibility complex-restricted antitumor immunity. J Exp Med 183:7, 1996
430. Santiago-Schwarz F, Rappa DA, Laky K, Carsons SE: Stem cell factor augments tumor necrosis factor-granulocyte-macrophage colony-stimulating factor-mediated dendritic cell hematopoiesis. Stem Cells 13:186, 1995
431. Lynch DH, Andreasen A, Maraskovsky E, Whitmore J, Miller RE, Schuh JCL: FH3 ligand induces tumor regression and anti-tumor immune responses in vivo. Nat Med 3:625, 1997
432. Chen K, Braun SE, Lyman SD, Broxmeyer HE, Cornelia K: Soluble and membrane bound isoforms of FLT3-ligand induce antitumor immunity in vivo. Blood 88:274a, 1996 (abstr, suppl 1)
433. Chen K, Braun S, Lyman S, Fan Y, Traycoff CM, Wiebke EA, Gaddy J, Sledge G, Broxmeyer HE, Cornetta K: Antitumor activity and immunotherapeutic properties of Flt3-ligand in a murine breast cancer model. Cancer Res 57:3511, 1997